EGFR and lung carcinoma: studied an orthotopic lung cancer mouse model driven by EGFR and found that treatment with EGFR‐TKIs could reduce tumor volume, accompanied by the infiltration of cytotoxic T lymphocytes (CTLs) and dendritic cells (DCs).